首页 › 血友病 › 印第安纳州 › Indianapolis
Indianapolis IN 血友病临床试验
9项针对 血友病的研究正在 Indianapolis及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
招募中3 期
- Innovative Hematology, Inc., Indianapolis
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
招募中1 期欢迎健康志愿者
- Indiana Hemophilia-Thromb Ctr, Indianapolis
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
招募中1/2 期
- Indiana Hemophilia & Thrombosis center, Indianapolis
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
招募中3 期
- Innovative Hematology, Inc., Indianapolis
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
招募中观察性研究
- Indiana Hemophilia and Thrombosis Center, Indianapolis
Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
招募中观察性研究
- Indiana Hemophilia & Thrombosis Center, Indianapolis
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
招募中1 期
- Innovative Hematology, Inc. (IHI), Indianapolis
Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
招募中4 期
- Innovative Hematology, Inc.- Site Number : 8400006, Indianapolis
Hemlibra in Mild Hemophilia A
招募中4 期
- Indiana Hemophila @Thrombosis Center, Indianapolis
其他城市的 血友病试验
- Los Angeles, CA7 项研究
- Seattle, WA6 项研究
- Cedar Rapids, IA6 项研究
- Philadelphia, PA5 项研究
- Little Rock, AR5 项研究
- Tampa, FL4 项研究
- Sacramento, CA4 项研究
- Dallas, TX4 项研究
- Atlanta, GA4 项研究
- Greenville, NC4 项研究
- Orange, CA4 项研究
- San Francisco, CA3 项研究
Indianapolis的其他研究
- 非小细胞肺癌32 项研究
- 癌症（所有类型）24 项研究
- 心力衰竭23 项研究
- 肥胖症20 项研究
- 乳腺癌20 项研究
- 转移性癌症19 项研究
- 结直肠癌18 项研究
- 卵巢癌17 项研究
- 心血管疾病17 项研究
- 肺癌16 项研究
- 1型糖尿病14 项研究
- 子宫内膜癌14 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。